New article: Cost-Effectiveness Analysis of Atezolizumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer With Different PD-L1 Expression Status https://t.co/ccge6RTTF6 #lungcancer #oncology https://t.co/k04A9GwGqz
906 followers
906 followers
New article: Cost-Effectiveness Analysis of Atezolizumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer With Different PD-L1 Expression Status https://t.co/qhP3KbS8IN #colorectalcancer #oncology https://t.co/Z2ueqM6lD
6,533 followers
New research: Cost-Effectiveness Analysis of Atezolizumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer With Different PD-L1 Expression Status: Background Atezolizumab could significantly improve clinical… https://t.